Device Dossier

Mycobacteria IVDs

Device Dossier for Mycobacteria IVDs (CT791 - Mycobacteria IVDs, Class 3, sponsor DiaSorin). ARTG record, intended purpose, GMDN category — compiled by…

Intended purpose

The device uses chemiluminescent immunoassay (CLIA) technology for the detection of interferon-γ (IFN-γ) in human lithium heparin plasma specimens. The immunoassay can identify in vitro responses to a peptide antigens cocktail associated with Mycobacterium tuberculosis (M. tuberculosis) infection (including disease). The assay is an indirect test intended as an aid in the diagnosis of M. tuberculosis infection.

TGA Public Summary